Shares of ICU Medical, Inc. (NASDAQ:ICUI – Get Free Report) have earned an average rating of “Moderate Buy” from the four ...

Fintel reports that on December 11, 2024, Jefferies upgraded their outlook for ICU Medical (NasdaqGS:ICUI) from Hold to Buy.

ICU Medical develops disposable medical connection ... In 1993 ICU launched CLAVE, a one-piece needleless IV connection device that has become the company's top selling product, accounting for ...

The stock has a market cap of $3.96 billion, a P/E ratio of -35.37 and a beta of 0.62. ICU Medical, Inc, together with its ...

In a report released yesterday, Michael Toomey from Jefferies upgraded ICU Medical (ICUI – Research Report) to a Buy, with a price target of ...

U.S. total addressable market for five initial indications is $25 to $33 billionREMINDER: Business Update Conference Call begins at 4:30 p.m.

04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ...

For the partnership, medical device maker ICU will join its North American production and distribution expertise, along with its IV pumps and consumables know-how, with Otsuka’s IV solution and ...

DENVER , Dec. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ...

ICUI) on Tuesday reported a loss of $33 million in its third quarter. The San Clemente, California-based company said it had a loss of $1.35 per share. Earnings, adjusted for amortization costs and ...

During the last three months, 4 analysts shared their evaluations of ICU Medical ICUI, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ...